Research ArticleCellular and Molecular
A Selective Antagonist Reveals a Potential Role of G Protein–Coupled Receptor 55 in Platelet and Endothelial Cell Function
Julia Kargl, Andrew J. Brown, Liisa Andersen, Georg Dorn, Rudolf Schicho, Maria Waldhoer and Akos Heinemann
Journal of Pharmacology and Experimental Therapeutics July 2013, 346 (1) 54-66; DOI: https://doi.org/10.1124/jpet.113.204180
Julia Kargl
Institute for Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria (J.K., L.A., G.D., R.S., M.W., A.H.); and Screening and Compound Profiling, GlaxoSmithKline, Medicines Research Centre, Stevenage, United Kingdom (A.J.B.)
Andrew J. Brown
Institute for Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria (J.K., L.A., G.D., R.S., M.W., A.H.); and Screening and Compound Profiling, GlaxoSmithKline, Medicines Research Centre, Stevenage, United Kingdom (A.J.B.)
Liisa Andersen
Institute for Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria (J.K., L.A., G.D., R.S., M.W., A.H.); and Screening and Compound Profiling, GlaxoSmithKline, Medicines Research Centre, Stevenage, United Kingdom (A.J.B.)
Georg Dorn
Institute for Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria (J.K., L.A., G.D., R.S., M.W., A.H.); and Screening and Compound Profiling, GlaxoSmithKline, Medicines Research Centre, Stevenage, United Kingdom (A.J.B.)
Rudolf Schicho
Institute for Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria (J.K., L.A., G.D., R.S., M.W., A.H.); and Screening and Compound Profiling, GlaxoSmithKline, Medicines Research Centre, Stevenage, United Kingdom (A.J.B.)
Maria Waldhoer
Institute for Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria (J.K., L.A., G.D., R.S., M.W., A.H.); and Screening and Compound Profiling, GlaxoSmithKline, Medicines Research Centre, Stevenage, United Kingdom (A.J.B.)
Akos Heinemann
Institute for Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria (J.K., L.A., G.D., R.S., M.W., A.H.); and Screening and Compound Profiling, GlaxoSmithKline, Medicines Research Centre, Stevenage, United Kingdom (A.J.B.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCellular and Molecular
Characterization of a GPR55 Antagonist
Julia Kargl, Andrew J. Brown, Liisa Andersen, Georg Dorn, Rudolf Schicho, Maria Waldhoer and Akos Heinemann
Journal of Pharmacology and Experimental Therapeutics July 1, 2013, 346 (1) 54-66; DOI: https://doi.org/10.1124/jpet.113.204180
Research ArticleCellular and Molecular
Characterization of a GPR55 Antagonist
Julia Kargl, Andrew J. Brown, Liisa Andersen, Georg Dorn, Rudolf Schicho, Maria Waldhoer and Akos Heinemann
Journal of Pharmacology and Experimental Therapeutics July 1, 2013, 346 (1) 54-66; DOI: https://doi.org/10.1124/jpet.113.204180
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement